New Solutions on the Horizon

Are you concerned about how plan sponsors will continue to fund innovative pharmaceutical therapies for their plan members?

At this webinar session we will be joined by industry leaders with expertise in the Changing Risk Landscape. We will begin by sharing a brief history of environmental factors that have changed risk and driven the demand for novel solutions for funding pharmaceutical benefits. Each expert will briefly speak to the need for new risk models, and innovative solutions that are being explored.


  • Jonathan Chan, Principal Consultant, People Corporation
  • Joe Farago, Executive Director, IMC
  • Eva Villalba, Executive Director, Quebec Cancer Coalition
  • Joan Weir, Vice President, Group Benefits, CLHIA

During our extended panel discussion our experts will explore the likelihood that these new risk models will be implemented and what patients, plan sponsors and insurers can expect as a result.

CE Credits

2.5 CE Credits available in most provinces when you participate in this session.


Thank you to our Benefits Breakfast Club (BBC) sponsors for their support:

Signature sponsors AMGEN, GlaxoSmithKline, Janssen Inc.

Leader sponsors AbbVie, Gilead, Lilly, MHCSI & Sobeys Pharmacy, Novo Nordisk, Roche

Emerging sponsors AstraZeneca, The Canadian Association of Optometrists, Incyte, Innovative Medicines Canada